Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home LSE Page 75

LSE

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Bacanora Lithium PLC (LON:BCN) had its Buy rating reiterated by VSA Capital

ME Staff - November 25, 2019

BBA Aviation (LON:BBA) price target raised to GBX 420 by Peel Hunt

Aggreko plc (LON:AGK) price target lowered to GBX 960 by Royal Bank of Canada

Associated British Foods plc (LON:ABF) price target raised to GBX 2,800 by Royal Bank of Canada

AVEVA Group plc (LON:AVV) had its Neutral rating reiterated by UBS Group with a GBX 4,365 price target

Capital & Counties Properties PLC (LON:CAPC) price target lowered to GBX...

ME Staff - February 15, 2019 0

BT Group (LON:BT_A) price target raised to GBX 340 by Jefferies...

ME Staff - February 15, 2019 0

Beazley PLC (LON:BEZ) price target lowered to GBX 650 by Jefferies...

ME Staff - February 15, 2019 0

Tritax Big Box REIT PLC (LON:BBOX) price target lowered to GBX...

ME Staff - February 15, 2019 0

AstraZeneca plc (LON:AZN) price target set to GBX 7,100 by JPMorgan...

ME Staff - February 14, 2019 0

AstraZeneca (LON:AZN) price target set to GBX 7,100 by JPMorgan Chase...

ME Staff - February 14, 2019 0

Restaurant Group (LON:RTN) had its Hold rating reiterated by Liberum Capital

ME Staff - February 14, 2019 0

Royal Dutch Shell Plc Class B (LON:RDSB) price target set to...

ME Staff - February 14, 2019 0

Puretech Health PLC (LON:PRTC) had its Buy rating reiterated by Liberum...

ME Staff - February 14, 2019 0

Motif Bio PLC (LON:MTFB) had its Under Review rating reiterated by...

ME Staff - February 14, 2019 0
1...747576...416Page 75 of 416

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019